Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix J Kim

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Cancers|May 16, 2023
Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate CancerJames Fradin, Felix J Kim, Grace L Lu-Yao, et al.
Blood|October 24, 2002
The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesisNicolas Manel, Sandrina Kinet, Jean-Luc Battini, et al.
Medecine Sciences : M/S|April 7, 2004
[GLUT-1 is the receptor of retrovirus HTLV]Nicolas Manel, Sandrina Kinet, Felix J Kim, et al.
Retrovirology|December 4, 2004
HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor bindingFelix J Kim, Nicolas Manel, Edith N Garrido, et al.
Molecular Pharmacology|January 22, 2010
Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor bindingFelix J Kim, Ivanka Kovalyshyn, Maxim Burgman, et al.
Biochemical and Biophysical Research Communications|August 29, 2012
Inhibition of tumor cell growth by Sigma1 ligand mediated translational repressionFelix J Kim, Joel M Schrock, Christina M Spino, et al.
Retrovirology|May 27, 2006
Intrahost variations in the envelope receptor-binding domain (RBD) of HTLV-1 and STLV-1 primary isolatesFelix J Kim, Madakasira Lavanya, Antoine Gessain, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2017
Novel small molecule guanidine Sigma1 inhibitors for advanced prostate cancerJoseph M Salvino, Yellamelli V V Srikanth, Rongliang Lou, et al.
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2004
HTLV envelopes and their receptor GLUT1, the ubiquitous glucose transporter: a new vision on HTLV infection?Nicolas Manel, Naomi Taylor, Sandrina Kinet, et al.
Molecular Cancer Research : MCR|November 10, 2017
Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1Christina M Maher, Jeffrey D Thomas, Derick A Haas, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cancers|May 16, 2023
Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate CancerJames Fradin, Felix J Kim, Grace L Lu-Yao, et al.
Blood|October 24, 2002
The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesisNicolas Manel, Sandrina Kinet, Jean-Luc Battini, et al.
Medecine Sciences : M/S|April 7, 2004
[GLUT-1 is the receptor of retrovirus HTLV]Nicolas Manel, Sandrina Kinet, Felix J Kim, et al.
Retrovirology|December 4, 2004
HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor bindingFelix J Kim, Nicolas Manel, Edith N Garrido, et al.
Molecular Pharmacology|January 22, 2010
Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor bindingFelix J Kim, Ivanka Kovalyshyn, Maxim Burgman, et al.
Biochemical and Biophysical Research Communications|August 29, 2012
Inhibition of tumor cell growth by Sigma1 ligand mediated translational repressionFelix J Kim, Joel M Schrock, Christina M Spino, et al.
Retrovirology|May 27, 2006
Intrahost variations in the envelope receptor-binding domain (RBD) of HTLV-1 and STLV-1 primary isolatesFelix J Kim, Madakasira Lavanya, Antoine Gessain, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2017
Novel small molecule guanidine Sigma1 inhibitors for advanced prostate cancerJoseph M Salvino, Yellamelli V V Srikanth, Rongliang Lou, et al.
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2004
HTLV envelopes and their receptor GLUT1, the ubiquitous glucose transporter: a new vision on HTLV infection?Nicolas Manel, Naomi Taylor, Sandrina Kinet, et al.
Molecular Cancer Research : MCR|November 10, 2017
Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1Christina M Maher, Jeffrey D Thomas, Derick A Haas, et al.
Pageof 3